• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Aerie Pharmaceuticals Inc

+ Add to Watchlist


19.0125 USD 0.4825 2.60%

As of 14:22:14 ET on 07/29/2014.

Snapshot for Aerie Pharmaceuticals Inc (AERI)

Open: 18.6500 Day's Range: 18.6500 - 19.4300 Volume: 275,073
Previous Close: 18.5300 52wk Range: 10.2500 - 29.7100 1-Yr Rtn: -

Stock Chart for AERI

No chart data available.
  • AERI:US 19.0200
  • 1D
  • 1M
  • 1Y
Interactive AERI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AERI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.3650
Est. PEG Ratio -
Market Cap (M USD) 443.19
Shares Outstanding (M) 23.44
30 Day Average Volume 525,488
Price/Book (mrq) 7.1292
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AERI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AERI

Aerie Pharmaceuticals, Inc. operates a clinical stage pharmaceutical company. The Company focuses on the discovery, development, and distribution of pharmaceutical products for the treatment of glaucoma and other disease of the eye. Aerie Pharmaceuticals offers its products to the medical industry.

Vicente Anido JrChairman/CEOThomas A MitroPresident/COO
Richard J Rubino "Rich"CFO/SecretaryBrian LevyChief Medical Officer
More Company Profile & Key Executives for AERI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil